Daniel Skovronsky - Feb 1, 2024 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP, CSO & Pres. LRL & LLY Imm
Signature
/s/ Jonathan Groff for Daniel Skovronsky, pursuant to authorization on file
Stock symbol
LLY
Transactions as of
Feb 1, 2024
Transactions value $
-$2,862,635
Form type
4
Date filed
2/2/2024, 04:25 PM
Previous filing
Nov 13, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Options Exercise $0 +9.94K +9.44% $0.00 115K Feb 1, 2024 Direct
transaction LLY Common Stock Tax liability -$2.86M -4.43K -3.85% $645.61 111K Feb 1, 2024 Direct
holding LLY Common Stock 70K Feb 1, 2024 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Options Exercise $0 -9.94K -100% $0.00* 0 Feb 1, 2024 Common Stock 9.94K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.